Targeting of Wnt–β-Catenin Pathway in Recurrent Ameloblastoma

AI Insight

This report describes targeting the Wnt–β-catenin signaling pathway in a patient with recurrent ameloblastoma, a locally aggressive jaw tumor. The approach represents a molecular-targeted therapeutic strategy for this benign but destructive odontogenic neoplasm that frequently requires extensive surgical resection. The case demonstrates potential for pathway-specific treatment in ameloblastomas with activated Wnt–β-catenin signaling.

Why it matters

This targeted approach could offer a less invasive alternative to extensive jaw surgery for recurrent ameloblastoma patients, potentially preserving facial structure and function. The findings suggest that molecular characterization of ameloblastomas may guide personalized treatment strategies and reduce patient morbidity.